Mixed lineage kinases activate MEK independently of RAF to mediate resistance to RAF inhibitors

被引：1
|
作者：
Marusiak, A. A. [1 ]
Edwards, Z. C. [1 ]
Hugo, W. [2 ]
Trotter, E. W. [1 ]
Girotti, M. R. [3 ]
Stephenson, N. L. [1 ]
Kong, X. [2 ]
Gartside, M. G. [4 ]
Fawdar, S. [1 ]
Hudson, A. [1 ]
Breitwieser, W. [3 ]
Hayward, N. K. [4 ]
Marais, R. [3 ]
Lo, R. S. [2 ]
Brognard, J. [1 ]
机构：
[1] Canc Res UK Manchester Inst, Signalling Networks Canc, Manchester, Lancs, England
[2] Jonsson Comprehens Canc Ctr, Div Dermatol, Los Angeles, CA 90034 USA
[3] Canc Res UK Manchester Inst, Manchester, Lancs, England
[4] QIMR Berghofer Med Res Inst, Brisbane, Qld, Australia
来源：
EUROPEAN JOURNAL OF CANCER | 2014年 / 50卷
关键词：
D O I：
10.1016/S0959-8049(14)70202-3
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
76
引用
收藏
页码：29 / 30
页数：2
相关论文
共 50 条
  • [21] The “SWOT” of BRAF Inhibition in Melanoma: RAF Inhibitors, MEK Inhibitors or Both?
    Moriah H. Nissan
    David B. Solit
    Current Oncology Reports, 2011, 13 : 479 - 487
  • [22] Tumor adaptation and resistance to RAF inhibitors
    Lito, Piro
    Rosen, Neal
    Solit, David B.
    NATURE MEDICINE, 2013, 19 (11) : 1401 - 1409
  • [23] ATMRK1, an Arabidopsis protein kinase related to mammal mixed-lineage kinases and Raf protein kinases
    Ichimura, K
    Mizoguchi, T
    Shinozaki, K
    PLANT SCIENCE, 1997, 130 (02) : 171 - 179
  • [24] Optimizing the Physicochemical Properties of Raf/MEK Inhibitors by Nitrogen Scanning
    Aoki, Toshihiro
    Hyohdoh, Ikumi
    Furuichi, Noriyuki
    Ozawa, Sawako
    Watanabe, Fumio
    Matsushita, Masayuki
    Sakaitani, Masahiro
    Morikarni, Kenji
    Takanashi, Kenji
    Harada, Naoki
    Tomii, Yasushi
    Shiraki, Koji
    Furumoto, Kentaro
    Tabo, Mitsuyasu
    Yoshinari, Kiyoshi
    Ori, Kazutomo
    Aoki, Yuko
    Shimma, Nobuo
    Iikura, Hitoshi
    ACS MEDICINAL CHEMISTRY LETTERS, 2014, 5 (04): : 309 - 314
  • [25] Targeted nanomedicines improve therapeutic indices of RAF and MEK inhibitors
    Heller, Daniel A.
    Shamay, Yosi
    CANCER RESEARCH, 2018, 78 (13)
  • [26] RAF Inhibitors Activate the MAPK Pathway by Relieving Inhibitory Autophosphorylation
    Holderfield, Matthew
    Merritt, Hanne
    Chan, John
    Wallroth, Marco
    Tandeske, Laura
    Zhai, Huili
    Tellew, John
    Hardy, Stephen
    Hekmat-Nejad, Mohammad
    Stuart, Darrin D.
    McCormick, Frank
    Nagel, Tobi E.
    CANCER CELL, 2013, 23 (05) : 594 - 602
  • [27] Analysis of the ERK Pathway Cysteinome for Targeted Covalent Inhibition of RAF and MEK Kinases
    Romany, Aarion
    Liu, Ruibin
    Zhan, Shaoqi
    Clayton, Joseph
    Shen, Jana
    JOURNAL OF CHEMICAL INFORMATION AND MODELING, 2023, 63 (08) : 2483 - 2494
  • [28] SIMULTANEOUS TARGETING OF RAF, MEK, AND ERK LIMITS DRUG RESISTANCE
    CANCER DISCOVERY, 2017, 7 (09) : 931 - 931
  • [29] Registered report: RAF inhibitors prime wild-type RAF to activate the MAPK pathway and enhance growth
    Bhargava, Ajay
    Pelech, Steven
    Ben Woodard
    Kerwin, John
    Maherali, Nimet
    ELIFE, 2016, 5
  • [30] Mechanisms of resistance to RAF inhibitors: literature review
    Rousseau, B.
    ONCOLOGIE, 2012, 14 (01) : 2 - 4
12345